Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer
Open Access
- 28 June 2021
- journal article
- research article
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 93 (2) , 148-152
Abstract
Objectives: It has been shown that the dysregulation of tyrosine kinase Axl receptor and its ligand growth arrest-specific gene (Gas6) are associated with poor prognosis in various types of tumors but there is not enough study about their importance in bladder cancer (BC). We evaluated the relation of Gas6 gene expression and tyrosine- kinase Axl and Sky (Tyro 3) receptors with tumor stage and grade in patients with BC. Material and Methods: The study group consists of 55 patients whose transurethral resection of bladder (TUR-B) has been performed due to BC and the control group consists of 12 patients with normal bladder mucosa. In tissues mRNAs of Gas6, Axl, and Sky receptors were examined by quantitative (Real-Time) PCR (qPCR). Protein expression was measured by immunohistochemistry. Plasma Gas6 protein levels were compared with control group by ELISA method. Results: Patients with BC were grouped as Ta low (n=17), Ta high (n=5), T1 low (n=9), T1 high (n=8) and T2 (n=16) according to their TUR-B pathologies. The qPCR analysis showed that the expression of Gas6 gene and Axl receptor is higher in the tumor-positive group and the immune-histochemical showed that the bladder samples of the tumor-positive group stained significantly positive. When the patients are grouped according to the TUR-B pathologies, a statistical significant difference was observed among groups in the qPCR analysis ratios of Gas6 gene and Axl receptor by (p < 0.05) but no significance was found for Sky receptor (p > 0.05). When Gas6 protein levels in plasma samples were compared by ELISA method, a statistical significance was determined among groups (p = 0.001). Conclusions: Our findings indicate that mRNAs of Gas6 and Axl receptor are closely related to tumor stage and grade in patients with BC. Further studies are needed for understanding the role of Gas6 and its receptors on the neoplastic transformation in terms of novel biomarkers and potential therapeutic targets.Keywords
This publication has 22 references indexed in Scilit:
- Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse PlateletsTurkish Journal of Hematology, 2015
- TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl KinaseCancer Research, 2013
- Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activitiesBiochemical and Biophysical Research Communications, 2013
- The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implicationsInternational Journal of Cancer, 2013
- Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancerBMC Cancer, 2011
- Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human bloodJournal of Thrombosis and Haemostasis, 2010
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast CancerCancer Research, 2010
- Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and SurvivalClinical Cancer Research, 2009
- Gas6 and protein SThe FEBS Journal, 2006
- The protein tyrosine kinase family of the human genomeOncogene, 2000